ArticleArtificial intelligence in medicine2021
An explainable AI system for automated COVID-19 assessment and lesion categorization from CT-scans.
Article in Artificial intelligence in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Explainable AI: A review of applications to neuroimaging data.Frontiers in neuroscience · 2022Pooled it
- Severity assessment of COVID-19 disease: radiological visual score versus automated quantitative CT parameters using a pneumonia analysis algorithm.Frontiers in medicine · 2025Article
- Optimising strategies for artificial intelligence-assisted classification of viral pneumonias on CT imaging: a comparative study of selective and default approaches.Polish journal of radiology · 2025Article
- Current Diagnostic Techniques for Pneumonia: A Scoping Review.Sensors (Basel, Switzerland) · 2024Article
- Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.Journal of Korean medical science · 2023Review
- Artificial Intelligence and Infectious Disease Imaging.The Journal of infectious diseases · 2023Article
- Clinical Implication and Prognostic Value of Artificial-Intelligence-Based Results of Chest Radiographs for Assessing Clinical Outcomes of COVID-19 Patients.Diagnostics (Basel, Switzerland) · 2023Article
- Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review.Frontiers in medicine · 2023Review
- An Explainable AI driven Decision Support System for COVID-19 Diagnosis using Fused Classification and Segmentation.Procedia computer science · 2023Article
- Explaining COVID-19 diagnosis with Taylor decompositions.Neural computing & applications · 2022Article
- COVID-19 Classification from Chest X-Ray Images: A Framework of Deep Explainable Artificial Intelligence.Computational intelligence and neuroscience · 2022Article
- Unsupervised Deep Learning based Variational Autoencoder Model for COVID-19 Diagnosis and Classification.Pattern recognition letters · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 infection caused by SARS-CoV-2 pathogen has been a catastrophic pandemic outbreak all over the world, with exponential increasing of confirmed cases and, unfortunately, deaths. In this work we propose an AI-powered pipeline, based on the deep-learning paradigm, for automated COVID-19 detection and lesion categorization from CT scans. We first propose a new segmentation module aimed at automatically identifying lung parenchyma and lobes. Next, we combine the segmentation network with classification networks for COVID-19 identification and lesion categorization. We compare the model's classification results with those obtained by three expert radiologists on a dataset of 166 CT scans. Results showed a sensitivity of 90.3% and a specificity of 93.5% for COVID-19 detection, at least on par with those yielded by the expert radiologists, and an average lesion categorization accuracy of about 84%. Moreover, a significant role is played by prior lung and lobe segmentation, that allowed us to enhance classification performance by over 6 percent points. The interpretation of the trained AI models reveals that the most significant areas for supporting the decision on COVID-19 identification are consistent with the lesions clinically associated to the virus, i.e., crazy paving, consolidation and ground glass. This means that the artificial models are able to discriminate a positive patient from a negative one (both controls and patients with interstitial pneumonia tested negative to COVID) by evaluating the presence of those lesions into CT scans. Finally, the AI models are integrated into a user-friendly GUI to support AI explainability for radiologists, which is publicly available at http://perceivelab.com/covid-ai. The whole AI system is unique since, to the best of our knowledge, it is the first AI-based software, publicly available, that attempts to explain to radiologists what information is used by AI methods for making decisions and that proactively involves them in the decision loop to further improve the COVID-19 understanding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.